AI assistant
VERACYTE, INC. — Director's Dealing 2021
Jun 8, 2021
31551_dirs_2021-06-08_c095af57-679c-443c-8430-3e80d5fad8fa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2021-06-04
Reporting Person: Kennedy Giulia C (Chief Scientific & Med Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-04 | Common Stock | M | 4406 | $5.98 | Acquired | 57218 | Direct |
| 2021-06-04 | Common Stock | M | 3750 | $20.21 | Acquired | 60968 | Direct |
| 2021-06-04 | Common Stock | S | 1507 | $33.279 | Disposed | 59461 | Direct |
| 2021-06-04 | Common Stock | S | 2595 | $34.3936 | Disposed | 56866 | Direct |
| 2021-06-04 | Common Stock | S | 4979 | $35.1702 | Disposed | 51887 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-04 | Stock Option (right to buy) | $5.98 | M | 4406 | Disposed | 2028-03-01 | Common Stock (4406.0) | Direct |
| 2021-06-04 | Stock Option (right to buy) | $20.21 | M | 3750 | Disposed | 2029-02-27 | Common Stock (3750.0) | Direct |
Footnotes
F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.
F2: Represents weighted average sales price. Sale prices for the transactions range from $32.92 to $33.68. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F3: Represents weighted average sales price. Sale prices for the transactions range from $33.93 to $34.93. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F4: Represents weighted average sales price. Sale prices for the transactions range from $34.95 to $35.27. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F5: The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter
F6: The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.